Opioid receptors and their ligands in the musculoskeletal system and relevance for pain control

Current Pharmaceutical Design

Volumn 19, Issue 42, 2013, Pages 7382-7390

  Spetea, Mariana ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Opioid receptor; Opioid receptor; Opioid receptor; Musculoskeletal tissues; Opioid peptides; Pain; Rheumatic disorders

Indexed keywords

ANALGESIC AGENT; BETA ENDORPHIN; DYNORPHIN; ENDORPHIN; ENKEPHALIN; LIGAND; OPIATE PEPTIDE; OPIATE RECEPTOR;

ACHILLES TENDON; ANALGESIA; AUTORADIOGRAPHY; BINDING ASSAY; BONE MARROW; CONNECTIVE TISSUE; ELECTRON MICROSCOPY; ELECTROPHYSIOLOGY; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL SYSTEM; NONHUMAN; OSTEOARTHRITIS; PERIOSTEUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM; WESTERN BLOTTING;

ANIMALS; HUMANS; LIGANDS; MUSCULOSKELETAL SYSTEM; PAIN; RECEPTORS, OPIOID;

EID: 84883278176     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990363     Document Type: Review

References (93)

1. Pasternak GW, Ed. The opiate receptors. New York: Humana Press 2011.
2. Fields H. Stage-dependent opioid control of pain. Nature Rev 2004; 5: 565-75.
3. Kapitzke D, Vetter I, Cabot PJ. Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control. Ther Clin Risk Manag 2005; 1: 279-97.
4. Pert CB, Snyder SH. Opiate receptor: Demonstration in nervous tissues. Science 1973; 179: 1011-14.
5. Simon EJ, Hiller JM, Edelman I. Stereospecific binding of the potent narcotic analgesic 3H-etorphine to rat brain homogenate. Proc Natl Acad Sci USA 1973; 70: 1947-9.
6. Terenius L. Characteristics of the receptor for narcotic analgesics in synaptic plasma membrane fraction from rat brain. Acta Pharmacol Toxicol (Copenh) 1973; 33: 377-84.
7. Kieffer B.L. Recent advances in molecular recognition and signal transduction of active peptides: Receptors for opioid peptides. Cell Mol Neurobiol 1995; 15: 615-35.
8. Knapp RJ, Malatynska E, Collins N, et al. Molecular biology and pharmacology of cloned opioid receptors. FASEB J 1995; 5: 516-25.
9. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE. The effects of morphine and nalorphine-dependent chronic spinal dog. J Pharmacol Ex. Ther 1976; 197: 517-32.
10. Lord JAH, Waterfield AA, Hughes J, Kosterlitz HW. Endogenous opioid peptides: Multiple agonists and receptors. Nature; 1977; 267: 495-9.
11. Evans CJ, Keith DE, Morrison H, et al. Cloning of the delta opioid receptor by functional expression. Science 1992; 258: 1952-55.
12. Kieffer BL, Befort K, Gaveriaux-Ruff C, et al. The delta opioid receptor: isolation of cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA 1992; 89: 12048-52.
13. Waldhoer M, Bartlett SE, Whistler JL. Opioid receptors. Annu Rev Biochem 2004; 73: 953-90.
14. Mansour A, Fox CA, Akil H, Watson SJ. Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications. Trends Neurosci 1995; 18: 22-9.
15. Elde R, Arvidsson U, Riedl M, et al. Distribution of neuropeptide receptors: New views of peptidergic neurotransmission made possible by antibodies to opioid receptors. Ann NY Acad Sci 1995; 757: 390-404.
16. Kieffer BL, Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog Neurobiol 2002; 66: 285-306.
17. Kieffer BL, Evans CJ. Opioid receptors: From binding sites to visible molecules in vivo. Neuropharmacology 2008; 56: 205-12.
18. Law PY. Opioid receptor signal transduction mechanisms. In: Pasternak GW, Ed. The opiate receptors. New York: Humana Press 2011; pp 195-238.
19. Dietis N, Rowbotham DJ, Lambert DG. Opioid receptor subtypes: Facts or artifact? Br J Anaesth 2011; 107: 8-18.
20. Rozenfeld R, Gomes I, Devi LA. Opioid receptor dimerization. In: Pasternak GW, Ed. The opiate receptors. New York: Humana Press 2011; pp 407-437.
21. Manglik A, Kruse AC, Kobilka TS, et al. Crystal structure of the opioid receptor bound to a morphinan antagonist. Nature 2012; 485: 321-6.
22. Granier S, Manglik A, Kruse AC, et al. Structure of the opioid receptor bound to naltrindole. Nature 2012; 485: 400-4.
23. Wu H, Wacker D, Mileni M, et al. Structure of the human opioid receptor in complex with JDTic. Nature 2012; 485: 327-32.
24. Hughes J, Smith TW, Kosterlitz H W, Fothergill LA, Morgan BA, Morris HR. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 1975; 258: 577-79.
25. Li CH. Chung D. Isolation and structure of a triakontapeptide with opiate activity from camel pituitary glands. Proc Natl Acad Sci USA 1976; 73: 1145-8.
26. Goldstein A, Tachibana S, Lowney LI, Hunkapiller M, Hood L. Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc Nat Acad Sci USA 1979; 76: 6666-70.
27. Zadina JE, Hackler L, Gee LJ, et al. A potent and selective endogenous agonist for the mu-opioid receptor. Nature 1997; 386: 499-02.
28. Berezniuk I, Fricker LD. Endogenous opioids. In: Pasternak GW, Ed. The opiate receptors. New York: Humana Press 2011; pp 93-120.
29. Noda M, Furutani Y, Takahashi H, et al. Cloning and sequence analysis of cDNA for bovine adrenal preproenkephalin. Nature 1982; 295: 202-6.
30. Goldstein A, Fischli W, Lowney LI, Hunkapiller M, Hood L. Porcine pituitary dynorphin: Complete amino acid sequence of the biologically active heptadecapeptide. Proc Natl Acad Sci USA 1981; 78: 7219-23.
31. Nakanishi S, Inoue A, Kita T, et al. Nucleotide sequence of cloned cDNA for bovine corticotropinlipotropin precursor. Nature 1979; 278: 423-7.
32. Pradhan AA, Smith ML, Kieffer BL, Evans CL. Ligand-directed signalling within the opioid receptor family. Br J Pharmacol 2012; 167: 960-9.
33. Rachel KM, Schmid CL, Groer CE, Bohn LM. Functional selectivity at the opioid receptor: Implications for understanding opioid analgesia and tolerance. Pharmacol Rev 2011; 63: 1001-19.
34. Cox BM. Pharmacology of opioid drugs. In: Pasternak GW, Ed. The opiate receptors. New York: Humana Press 2011; pp 23-57.
35. Vallejo R, Barkin RL, Wang VC. Pharmacology of opioids in the treatment of chronic pain syndromes. Pain Physician 2011; 14: E343-60.
36. Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician 2008; 11: S105-20.
37. Graziottin A, Gardner-Nix J, Stumpf M, Berliner MN. Opioids: How to improve compliance and adherence. Pain Practice 2011; 11: 1-8.
38. Bergman S. Management of musculoskeletal pain. Best Pract Res Clin Rheumatol. 2007; 21: 153-66.
39. Lang LJ, Pierer M, Stein C, Baerwald C. Opioids in rheumatic diseases. Ann NY Acad Sci 2010; 1193; 111-6.
40. Nagy I, Lukacs KV, Urban L. Mechanisms underling joint pain. Drug Discov Today 2006; 3: 357-63.
41. Stein C, Clark JD, Oh U, et al. Peripheral mechanisms of pain and analgesia. Brain Res Rev 2009; 60: 90-113.
42. Russell NJ, Schaible HG, Schmidt RF. Opiates inhibit the discharges of fine afferent units from inflamed knee joint of the cat. Neurosci Lett 1987; 76: 107-12.
43. Stein C, Comisel K, Haimaeri E, Yassouridis A, Lehrberger K. Analgesic effects of intraarticular morphine after arthroscopic knee surgery. N Engl J Med 1991; 325: 1123-6.
44. Lawrence AJ, Joshi GP, Michalkiewicz A, Blunnie WP, Moriarty DC. Evidence for analgesia mediated by peripheral opioid receptors in inflamed synovial tissue. Eur J Clin Pharmacol 1992; 43: 351-5.
45. Stein C, Hassan AHS, Lehrberger K, Giefing J, Yassouridis A. Local analgesic effect of endogenous opioid peptides. Lancet 1993; 342: 321-4.
46. Stein C, Pfluger M, Yassouridis A, et al. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J Clin Invest 1996; 98: 793-9.
47. Takeba Y, Suzuki N, Kaneko A, Asai T, Sakane T. Endorphin and enkephalin ameliorate excessive cell function in patients with rheumatoid arthritis. J Rheumatol 2001; 28: 2176-83.
48. Sheehy JG, Hellyer PW, Sammonds GE, et al. Evaluation of opioid receptors in synovial membranes of horses. Am J Vet Res 2001; 62: 1408-12.
49. Keates HL, Cramond T, Smith MT. Intraarticular and periarticular opioid binding in inflamed tissue in experimental canine arthritis. Anesth Analg 1999; 89: 409-15.
50. Bergström J, Ahmed M, Li J, Ahmad T, Kreicbergs A, Spetea M. Opioid receptors and peptides in joint tissues. A study in the rat. J Orthopaed Res 2006; 24: 1193-19.
51. Ackermann PW, Spetea M, Nylander I, Ploj K, Ahmed M, Kreicbergs A. An opioid system in connective tissue: A study of Achilles tendon in the rat. J Histochem & Cytochem 2001; 49: 1387-95.
52. Castano MT, Freire-Garabal M, Giraldez M, et al. 1991 Autoradiographic evidence of 125I-endorphin binding sites in the articular cartilage of the rat. Life Sci 1991; 49: PL103-PL105.
53. Freire-Garabal M, Castano MT, Belmonte A, Jorge J, Couceiro J, Nunez MJ. Autoradiographic evidence of opioid binding sites in rat growth plate chondrocytes. Neuroendocrinology 1992; 55: 357-9.
54. Zöllner C, Shaqura MA, Bopaiah CP, Mousa S, Stein C, Schäfer M. Painful inflammation-induced increase in opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol 2003; 64: 202-10.
55. Shaqura MA, Zollner C, Mousa SA, Stein C, Schäfer M. Characterization of opioid receptor binding and G-protein coupling in rat hypothalamus, spinal cord and primary afferent neurons during inflammatory pain. J Pharmacol Exp Ther 2004; 308: 712-8.
56. Mousa SA, Straub RH, Schäfer M, Stein C. Endorphin, Metenkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis. Ann Rheum Dis 2007; 66: 871-9.
57. Tanaka N, Sakahashi H, Sato E, Hirose K, Ishii S. The efficacy of intra-articular analgesia after total knee arthroplasty in patients with rheumatoid arthritis and in patients with osteoarthritis. J Arthroplasty 2001; 16: 306-11.
58. van Loon JPAM, de Grauw JC, Brunott A, Weerts EAWS, van Weeren PR. Upregulation of articular synovial membrane opioidlike receptors in an acute equine synovitis model. Vet J 2012; http://dx.doi.org/10.1016/j.tvjl.2012.07.030,
59. Inglis JI, McNamme KE, Chia S-L, et al. Regulation of pain sensitivity in experimental osteoarthritis by the endogenous peripheral opioid system. Arth Rheum 2008; 58: 3110-9.
60. Hayashi K, Sugisaiki M, Ota S, Tanabe H. Opioid receptor mRNA expression and imunohistochemical localization in the rat temporomandibular joint. Peptides 2002; 23: 889-93.
61. McDougall JJ, Barin AK, McDougall CM. Loss of vascular responsiveness to the mu-opioid receptor ligand endomorphin-1 in adjuvant monoarthritic rat knee joints. Am J Physiol Regul Integr Comp Physiol 2004; 4: R634-41.
62. Elvenes J, Andjelkov N, Figenshau Y, Seternes T, Bjorkoy G, Johansen O. Functional expression of opioid receptors in human osteoarthritic cartilage and chondrocytes. Biochem Biophys Res Commun 2003; 311: 202-7.
63. Garcia-Castellano JM, Diaz-Herrera P, Morcuende JA. Is bone a target tissue for the nervous system? New advances on the understanding of their interactions. Iowa Orthop J 2000; 20: 49-58.
64. Conney TE, Konieczko EM, Roach L, Poole B. Fate of mu receptors during rat skeletogenesis. Orthopedics 2009; 32: 95.
65. Shen H, Aechlimann A, Reisch N, et al. Kappa and delta opioid receptors are expressed but down-regulated in fibroblast-like synoviocytes of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 2005; 52: 1402-10.
66. Walker JS, Howlett CR, Nayanar V. Anti-inflammatory effects of kappa-opioids in adjuvant arthritis. Life Sci 1995; 57: 371-8.
67. Wilson JL, Nayanar V, Walker JS The site of anti-arthritic action of the kappa-opioid, U-50,488H, in adjuvant arthritis: Importance of local administration. Br J Pharmacol 1996; 118: 1754-60.
68. Binder W, Walker JS. Effect of the peripherally selective kappaopioid agonist, asimadoline, on adjuvant arthritis. Br J Pharmacol 1998; 1244: 647-54.
69. Stein C, Gramsch C, Herz A, Intrinsic mechanisms of antinociception in inflammation. Local opioid receptors and endorphin. J Neurosci 1990; 10: 1292-8.
70. Stein C, Hassan AH, Przewlocki R, Gramsch C, Peter K, Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA 1990; 87: 5935-9.
71. Stein C, Machelska H. Modulation of peripheral sensory neurons by the immune system: Implications for pain therapy. Pharmacol Rev 2011; 63: 860-81.
72. Gibbins IL, Furness JB, Costa M, Pathway-specific patterns of the co-existence of substance P, calcitonin gene-related peptide, cholecystokinin and dynorphin in neurons of the dorsal root ganglia of the guinea pig. Cell Tissue Res1987; 248: 417-37.
73. Crowe R, Parkhouse N, McGrouther D, Burnstock G. Neuropeptide-containing nerves in painful hypertrophic human scar tissue. Br J Dermatol 1994; 130: 444-52.
74. Carlton SM, Coggeshall RE. Immunohistochemical localization of enkephalin in peripheral sensory axons in the rat. Neurosci Lett 1997; 221: 121-4.
75. Shiga H, Yoshino S, Nakamura H, Koiwa M. Role of opioid peptide in rheumatoid arthritis-detection of methionine-enkephalin and leucine-enkephalin in synovial tissue. Arerugi 1993; 42: 243-9.
76. Elhassan AM, Lindgren U, Hultenby K, Bergstrom J, Adem A. Methionine-enkephalin in bone and joint tissues. J Bone Min Res 1998; 13: 88-95.
77. Abramovici A, Daizade I, Yosipovitch Z, Gibson SJ, Polak JM. The distribution of peptide-containing neurons in the synovia of the cat knee joint. Histol Histopathol 1991; 6: 469-76.
78. Quinyang W, Lindgren JU, Elhassa AM, Hultenby K. Distibution of leucine-enkephalin in bone and joint tissues. Neuropeptides 2002; 36: 4: 281-6.
79. Quinyang W, Hultenby K, Lindgren JU. Tissue levels of leuenkephalin in rats with adjuvant arthritis. J. Neuroimmunol 2005; 158: 34-9.
80. Bergström J, Ahmed M, Kreicbergs A, Nylander I. Purification and quantification of opioid peptides in bone and joint tissues a methodological study in the rat. J Orthopaedic Res 2003; 465-9.
81. Elfvin LG, Holmberg K, Johansson J, Aldskogius H. The innervation of the synovium of the knee joint in the guinea pig: An immunohistochemical and ultrastructural study. Anat Embryol 1998; 197: 293-303.
82. Hassan AH, Pzew ocki R, Herz A, Stein C. Dynorphin, a preferential ligand for opioid receptors, is present in nerve fibers and immune cells within inflamed tissue of the rat. Neurosci Lett 1992; 140: 85-8.
83. Böhm M, Grässel S. Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: From basic to translational research. Endocr Rev 2012; 33: 623-51.
84. Denko CW, Aponte J, Gabriel P, Petricevic M. Endorphin, immunological and biochemical changes in synovial fluid in rheumatic disorders. Clin Rheumatol 1986; 5: 25-32.
85. Toth K, Barna I, Nagy G, Wellinger K, Horvath G, Bender T. Synovial fluid endorphin level in avascular necrosis, rheumatoid arthritis, and osteoarthritis of the femoral head and knee. A controlled pilot study. Clin Rheumatol 2011; 30: 537-40.
86. Suzuki N, Yoshino S, Nakamura H. A study of opioid peptides in synovial fluid and synovial tissue in patients with rheumatoid arthritis. Arerugi 1992; 41:615-20.
87. Koiwa M, Shiga H, Nakamura H, Yoshino S. Role of opioid peptide in rheumatoid arthritis: detection of endorphin in synovial tissue. Arerugi 1992; 41: 1423-9.
88. Andjelkov N, Elvenes J, Figenschau Y, et al. Detection of mRNA transcripts of truncated opiate precursor (POMC) in human cartilage. Cell Biochem Funct 2006; 24: 229-35.
89. Karahan S, Kincaid SA, Baird AN, Kammermann JR. Distribution of endorphin and substance P in the shoulder joint of the dog before and after a low impact exercise programme. Anat Histol Embryol 2002; 31: 72-7.
90. Fichna J, Janecka A, Costentin J, Do Rego J-C. The endomorphin system and its evolving neurophysiological role. Pharmacol Rev 2007; 59: 88-123.
91. Jessop DS, Fassold A, Wolff C, et al. Endomorphins in rheumatoid arthritis, osteoarthritis, and experimental arthritis. Ann NY Acad Sci 2010; 1193: 117-22.
92. Jessop DS, Richard LS, Harbut MS. Opioid peptides endomorphin 1 and endomorphin 2 in the immune system in humans and in a rodent model of inflammation. Ann NY Acad Sci 2002; 966: 456-63.
93. Straub RH, Wolff C, Fassold A, et al. Antiinflammatory role of endomorphins in osteoarthritis, rheumatoid arthritis, and adjuvantinduced polyarthritis. Arthritis Rheum 2008; 58: 456-66.